15 november 2020
In addition to the good news around the vaccine from Pfizer and its partner BioNTech, a second covid vaccine is also in sight.
The corona vaccine from the University of Oxford and the pharmaceutical company AstraZeneca is almost ready. The vaccine is in phase three, which means it is close to approval. This is reported by the Belgian CEO Bruno Holthof of Oxford University Hospitals in the TV program De Zevende Dag.
On Monday, Pfizer announced that it had produced a high-performance corona vaccine with its partner BioNTech. This led to a lot of optimism in the world and in the financial markets, because it seems that an end to the corona crisis is in sight. According to research results, the vaccine would protect nine out of ten vaccinated subjects against infection with the virus.
Holthof does not report percentages on the effectiveness of the vaccine. He emphasizes that the high degree of protection of Pfizer’s vaccine is also encouraging news for the other corona vaccines. ‘The vaccines will all elicit an immune response against that spine protein, which means that it was the right choice to put that first.’
An important advantage of the AstraZeneca vaccine is that it is less difficult to store than the Pfizer vaccine. The latter vaccine must be stored at -80 degrees Celsius, while the AstraZeneca vaccine only needs to be stored in a normal refrigerator.
These were the details of the news Second covid vaccine almost ready | The time for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at news1.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.